GILEAD SCIENCES INC Insider Trading for November 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for November 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Gift | G | 0.00 | 306,400 | 0 | 4,122,987 | 4.4 M to 4.1 M (-6.92 %) |
| Nov 25 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 2,869 | 0 | 43,839 | 41 K to 43.8 K (+7.00 %) |
| Nov 25 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 2,869 | 0 | 49,832 | 52.7 K to 49.8 K (-5.44 %) |
| Nov 25 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 1,500 | 0 | 40,970 | 42.5 K to 41 K (-3.53 %) |
| Nov 25 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 14.34 | 25,000 | 358,438 | 26,000 | |
| Nov 25 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 102.51 | 2,500 | 256,275 | 42,405 | 44.9 K to 42.4 K (-5.57 %) |
| Nov 25 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 101.55 | 7,515 | 763,172 | 44,905 | 52.4 K to 44.9 K (-14.34 %) |
| Nov 25 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 100.86 | 14,985 | 1,511,323 | 52,420 | 67.4 K to 52.4 K (-22.23 %) |
| Nov 25 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 14.34 | 25,000 | 358,438 | 67,405 | 42.4 K to 67.4 K (+58.96 %) |
| Nov 12 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 8.01 | 146,895 | 1,175,894 | 146,823 | |
| Nov 12 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 108.77 | 7,346 | 799,028 | 974,048 | 981.4 K to 974 K (-0.75 %) |
| Nov 12 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 107.71 | 73,187 | 7,882,642 | 981,394 | 1.1 M to 981.4 K (-6.94 %) |
| Nov 12 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 106.85 | 66,362 | 7,091,065 | 1,054,581 | 1.1 M to 1.1 M (-5.92 %) |
| Nov 12 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 8.01 | 146,895 | 1,175,894 | 1,120,943 | 974 K to 1.1 M (+15.08 %) |
| Nov 07 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 0.00 | 6,000 | 0 | 6,000 | |
| Nov 07 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 106.05 | 3,131 | 332,043 | 52,701 | 55.8 K to 52.7 K (-5.61 %) |
| Nov 07 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 0.00 | 6,000 | 0 | 55,832 | 49.8 K to 55.8 K (+12.04 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 23.76 | 31,000 | 736,405 | 42,367 | |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 112.04 | 600 | 67,222 | 118,694 | 119.3 K to 118.7 K (-0.50 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 110.44 | 300 | 33,131 | 119,294 | 119.6 K to 119.3 K (-0.25 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 109.86 | 1,100 | 120,841 | 119,594 | 120.7 K to 119.6 K (-0.91 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 112.45 | 1,115 | 125,379 | 120,694 | 121.8 K to 120.7 K (-0.92 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 111.89 | 6,877 | 769,490 | 121,809 | 128.7 K to 121.8 K (-5.34 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 110.45 | 3,350 | 370,017 | 128,686 | 132 K to 128.7 K (-2.54 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 109.89 | 19,658 | 2,160,302 | 132,036 | 151.7 K to 132 K (-12.96 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 23.76 | 31,000 | 736,405 | 151,694 | 120.7 K to 151.7 K (+25.68 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 40.56 | 5,592 | 226,812 | 50,342 | |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 24.30 | 11,250 | 273,319 | 56,250 | |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 23.76 | 4,800 | 114,024 | 4,800 | |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 19.09 | 11,550 | 220,432 | 11,550 | |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 112.24 | 1,700 | 190,814 | 49,832 | 51.5 K to 49.8 K (-3.30 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 111.69 | 2,775 | 309,936 | 51,532 | 54.3 K to 51.5 K (-5.11 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 110.15 | 21,435 | 2,361,057 | 54,307 | 75.7 K to 54.3 K (-28.30 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 109.59 | 7,282 | 798,030 | 75,742 | 83 K to 75.7 K (-8.77 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 40.56 | 5,592 | 226,812 | 83,024 | 77.4 K to 83 K (+7.22 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 24.30 | 11,250 | 273,319 | 77,432 | 66.2 K to 77.4 K (+17.00 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 23.76 | 4,800 | 114,024 | 66,182 | 61.4 K to 66.2 K (+7.82 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 19.09 | 11,550 | 220,432 | 61,382 | 49.8 K to 61.4 K (+23.18 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 140,633 | |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 112.42 | 9,025 | 1,014,617 | 4,429,387 | 4.4 M to 4.4 M (-0.20 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 111.83 | 20,400 | 2,281,405 | 4,438,412 | 4.5 M to 4.4 M (-0.46 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 110.17 | 55,454 | 6,109,190 | 4,458,812 | 4.5 M to 4.5 M (-1.23 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 109.78 | 55,746 | 6,119,891 | 4,514,266 | 4.6 M to 4.5 M (-1.22 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 0.00 | 4,800 | 0 | 12,500 | |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 3,000 | 121,680 | 21,240 | |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 109.72 | 2,736 | 300,194 | 34,308 | 31.6 K to 34.3 K (+8.67 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 0.00 | 4,800 | 0 | 37,044 | 32.2 K to 37 K (+14.89 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 112.46 | 3,000 | 337,380 | 32,244 | 35.2 K to 32.2 K (-8.51 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 3,000 | 121,680 | 35,244 | 32.2 K to 35.2 K (+9.30 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 26.99 | 5,000 | 134,950 | 20,000 | |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 112.02 | 5,000 | 560,090 | 15,641 | 20.6 K to 15.6 K (-24.22 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 26.99 | 5,000 | 134,950 | 20,641 | 15.6 K to 20.6 K (+31.97 %) |